Pharmacovigilance Solutions

PV and safety teams are charged with ensuring adherence to regulatory and legal policies while putting patient safety above all else. TransPerfect supports these efforts with technology and services that help pharma, biotech, and med device companies ensure the safety of their patients by accelerating the time to report safety cases.

Get in Touch
Clinician using clipboard to mark off drug information

24/7 Support to Ensure Patient Safety Anytime, Anywhere

24/7 Support to Ensure Patient Safety Anytime, Anywhere

Why PV & Safety Teams Love TransPerfect

Our knowledge and experience in pharmacovigilance is evidenced by our ability to create and curate strategic solutions to improve day-to-day operations / reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

Literature Search

Improve your multilingual literature monitoring process with our comprehensive solution, which enables the collation, search, delivery, and translation of local and international literature (published and scientific) for adverse events.

Learn More ›

Call Center Support

Field non-English SA/SAE reporting with our world-class call center support division, TP Connect. With more than 100 global offices, we have helped many pharma companies quickly report and act on adverse events called in all over the world.

Learn More ›

AI Portal for Case Triage

Automate your translation process for faster turnaround times while also enabling your case processor to quickly prioritize incoming reports based on seriousness across 200+ languages.

Learn More ›

Language/Translation Solutions

Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

Learn More ›

Training & Development

Whether your needs are temporary or ongoing, we help PV & safety teams select, test, train, and onboard multilingual staff to support outbound patient surveillance calls. Ensure your staff is trained with localized content and training materials for international markets, hosted in a 21 CFR Part 11 data room capable of generating reports on compliance.

Learn More ›

eClinical

Maintain compliance and enhance patient safety with the Trial Interactive PMSF solution. An easy-to-use, web-based format, our technology solution traffics safety notifications and distributes alerts in real time, ensuring that sites, sponsors, and CROs remain fully apprised of the latest information and data to meet good pharmacovigilance practices (GVP) and, of course, patient safety standards.

Learn More ›

Redaction

All safety reports contain personally identifiable information (PII) of patients. Protect patient safety and privacy with our redaction services prior to regulatory review.

Learn More ›

Medical Writing

When it comes to creating, managing, and translating safety content, medical writers play an integral role in protecting patient safety and adhering to strict regulations within tight deadlines. Our team of expert medical writers has in-depth knowledge of best practices for drafting and maintaining safety content, including PSURs/PBRERs, DSURs, RMPs, and more.

Learn More ›

Social Media Monitoring

Enhance patients’ real-world usage and feedback, including detecting potential adverse events, with multilingual social media monitoring.

Learn more ›

Trusted by Life Sciences Organizations Big and Small

News and Press Releases

Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

AI and Medical Device Regulations: Why Human Experts Still Sign Off

In our previous post, we covered the EUDAMED deadline for SSCPs and SSPs, which came up again and again at the RAPS Convergence Conference in Charlotte, North Carolina. In this post, we’re diving into another theme that was just as hard to miss: what AI means for the people who do regulatory work. That was the subject of an overflow session titled “How Is AI Affecting the Regulatory Workforce?” The question behind most of the discussion: Will AI take our jobs? The ...

AI and Medical Device Regulations: Why Human Experts Still Sign Off

How to Select the Right Regulatory Writing Company for Your Organization's Needs

In a landscape defined by ever-evolving global guidelines from health authorities, many life sciences organizations’ clinical and regulatory teams face challenges in navigating the regulatory affairs writing and document submission process. Adhering to strict rules while...

LifeSci Talks COA Series | Clinical Trial Site Burden: Why One Study Can Mean Up to 15 Systems

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of Clinical Technologies at Almac Clinical Technologies, to talk about the burden clinical trial sites face when one study runs on up to ...

Governing AI for Global Content in the Life Sciences Industry

AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and ...

MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

As soon as possible, but no later than March 27, 2027 (per MDCG 2026-4), medical device manufacturers must upload their validated, translated Summaries of Safety and Clinical Performance (SSCPs) to EUDAMED themselves. IVD manufacturers have the same responsibility for their...

Reddit Stories: AI Failures in Clinical Trials

Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...

Are Legacy COA Instruments Still Fit for Purpose?

The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....

Talk to Us About Your Global PV and Safety Programs

Get a free consultation.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.